Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene.
The xanthine oxidoreductase gene (XOR) encodes an important source of reactive oxygen species and uric acid, and its expression is associated with various human diseases including several forms of cancer. We previously reported that basal human XOR (hXOR) expression is restricted or repressed by E-box and TATA-like elements and a cluster of transcriptional proteins, including AREB6-like proteins and DNA-dependent protein kinase (DNA-PK). We now demonstrate that the cluster contains the tumor suppressors SAFB1, BRG1, and SAF-A. We further demonstrate that SAFB1 silencing increases hXOR expression and that SAFB1 directly binds to the E-box. Multiple studies in vitro and in vivo including pulldown, immunoprecipitation and chromatin immunoprecipitation analyses indicate that SAFB1, Ku86, and BRG1 associate with each other. The results suggest that the SAFB1 complex binds to the hXOR promoter in a chromatin environment and plays a critical role in restricting hXOR expression via its direct interaction with the E-box, DNA-PK, and tumor suppressors. Moreover, we demonstrate that the cytokine, oncostatin M (OSM), induces the phosphorylation of SAFB1 and that the OSM-induced hXOR mRNA expression is significantly inhibited by silencing the DNA-PK catalytic subunit or SAFB1 expression. The present studies for the first time demonstrate that hXOR is a tumor suppressor-targeted gene and that the phosphorylation of SAFB1 is regulated by OSM, providing a molecular basis for understanding the role of SAFB1-regulated hXOR transcription in cytokine stimulation and tumorigenesis.
Lin
Junji
J
Department of Internal Medicine, Division of Respiratory, Critical Care, and Occupational Medicine, University of Utah Health Sciences Center and Veterans Affairs Medical Center, Salt Lake City, Utah 84132, USA.
Xu
Ping
P
LaVallee
Patricia
P
Hoidal
John R
JR
D034961:Antigens, Nuclear / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D047369:Chromatin Immunoprecipitation; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D006801:Humans; D000072200:Ku Autoantigen; D036961:Matrix Attachment Region Binding Proteins / Q000378:metabolism*; D008954:Models, Biological; D034521:Nuclear Matrix-Associated Proteins / Q000378:metabolism*; D053683:Oncostatin M / Q000378:metabolism*; D010766:Phosphorylation; D011960:Receptors, Estrogen / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry; D014158:Transcription, Genetic; D014968:Xanthine Dehydrogenase / Q000378:metabolism*
D034961:Antigens, Nuclear; D016207:Cytokines; D004268:DNA-Binding Proteins; D036961:Matrix Attachment Region Binding Proteins; D034521:Nuclear Matrix-Associated Proteins; D011960:Receptors, Estrogen; D011994:Recombinant Proteins; C109132:SAFB protein, human; D053683:Oncostatin M; D014968:Xanthine Dehydrogenase; C000606509:Xrcc6 protein, human; D000072200:Ku Autoantigen
Genes Dev. 1999 Apr 15;13(8):916-34
10215620
J Physiol. 2004 Mar 16;555(Pt 3):589-606
14694147
Nature. 2003 Oct 2;425(6957):516-21
14520412
Science. 1991 Dec 6;254(5037):1512-5
1660188
Ugeskr Laeger. 1994 Apr 18;156(16):2396-401
8009701
Toxicology. 2001 Mar 7;160(1-3):11-8
11246119
Cancer Res. 2004 Aug 1;64(15):5059-62
15289304
Mol Cell Biol. 1999 Jun;19(6):4065-78
10330147
Proc Soc Exp Biol Med. 1996 Apr;211(4):366-73
8618943
Basic Res Cardiol. 1987 Sep-Oct;82(5):486-92
3426527
Trends Genet. 1996 Jun;12(6):229-34
8928228
J Clin Invest. 1990 Mar;85(3):739-45
2155924
Biochem J. 1996 Sep 1;318 ( Pt 2):379-82
8809022
Am J Physiol. 1988 Dec;255(6 Pt 2):H1269-75
3059826
Chem Res Toxicol. 1999 Feb;12(2):180-6
10027796
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7638-42
2217195
J Immunol. 1994 Aug 15;153(4):1789-97
8046245
J Biol Chem. 2004 Apr 16;279(16):16057-63
14761964
Oncogene. 2000 May 15;19(21):2628-37
10851062
J Biol Chem. 1969 Apr 10;244(7):1682-91
5813728
Trends Biochem Sci. 1994 Jan;19(1):38-42
8140620
Kidney Int. 1986 Feb;29(2):478-83
3702206
Cancer Lett. 2005 Sep 28;227(2):133-9
16112416
Nucleic Acids Res. 1996 Mar 1;24(5):843-9
8600450
J Biol Chem. 2001 May 18;276(20):16848-56
11279128
Biochem Soc Trans. 1993 Nov;21(4):930-5
8132096
Biochem Soc Trans. 1997 Aug;25(3):786-91
9388546
Curr Protoc Mol Biol. 2001 May;Chapter 10:Unit 10.16
18265056
Biochem Biophys Res Commun. 1994 Mar 15;199(2):998-1004
8135849
Eur J Biochem. 1997 May 1;245(3):541-8
9182988
Kidney Int. 1991 Dec;40(6):1041-9
1662318
Arch Biochem Biophys. 1976 Feb;172(2):365-79
176940
J Biol Chem. 1977 Oct 10;252(19):6721-8
197102
Br J Cancer. 1999 Aug;80(12):1968-73
10471047
Proc Natl Acad Sci U S A. 1981 Nov;78(11):6858-62
6947260
Biochem J. 1986 May 1;235(3):747-54
3753442
Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15944-8
15486091
Antioxid Redox Signal. 2000 Winter;2(4):903-17
11213491
Nucleic Acids Res. 1991 May 11;19(9):2499
2041787
Nutr Cancer. 2007;59(1):8-13
17927496
J Clin Invest. 1989 Apr;83(4):1137-43
2539390
AACN Clin Issues. 2002 Nov;13(4):540-9
12473916
Biochemistry (Mosc). 2000 Jan;65(1):2-27
10702637
Cancer Res. 2003 Feb 1;63(3):560-6
12566296
Kidney Int. 1991 Aug;40(2):291-301
1942778
Biochem J. 1992 Aug 1;285 ( Pt 3):1001-8
1379796
J Biol Chem. 1994 Jan 14;269(2):1449-59
8288611
EMBO J. 1992 Sep;11(9):3431-40
1324173
Pflugers Arch. 1989 Nov;415(2):127-35
2556684
Free Radic Biol Med. 2002 Sep 15;33(6):774-97
12208366
Am J Physiol. 1990 Mar;258(3 Pt 2):F711-6
2316673
J Biol Chem. 2000 Feb 25;275(8):5918-26
10681584
Chest. 1999 Jul;116(1 Suppl):56S-61S
10424593
Breast Cancer Res. 2000;2(2):116-24
11250701
Cancer Res. 2003 May 15;63(10):2440-6
12750264
Breast Cancer Res. 2002;4(2):70-6
11879567
Biochim Biophys Acta. 1989 Apr 25;991(1):79-84
2713424
J Biol Chem. 2002 Apr 5;277(14):11617-20
11805123
Curr Biol. 1999 Dec 16-30;9(24):R936-8
10607581
Genomics. 1994 Sep 1;23(1):289-91
7829092
J Clin Invest. 1992 Jan;89(1):197-202
1370294
FASEB J. 1996 May;10(7):709-20
8635688
Annu Rev Pharmacol Toxicol. 2004;44:239-67
14744246
Am J Physiol. 1994 Feb;266(2 Pt 1):L163-71
8141312
Mol Cell Biol. 2004 Jan;24(1):362-76
14673169
Free Radic Biol Med. 2002 Jun 1;32(11):1102-15
12031895
Free Radic Biol Med. 1999 Feb;26(3-4):348-54
9895226
Chem Res Toxicol. 2000 Aug;13(8):793-800
10956068
J Biol Chem. 1960 Dec;235:3544-50
13716276
Chem Res Toxicol. 2002 Apr;15(4):536-44
11952340
J Biol Chem. 1990 Aug 25;265(24):14170-5
2387845
Br J Cancer. 2001 Feb;84(4):493-8
11207044
Circ Res. 2004 Nov 26;95(11):1118-24
15528468
Genes Dev. 2002 Dec 15;16(24):3223-35
12502743
Expert Rev Mol Diagn. 2003 Sep;3(5):573-85
14510178
J Cell Physiol. 2003 Jul;196(1):19-41
12767038
J Appl Physiol (1985). 1987 Nov;63(5):2159-63
2826385
Eur J Biochem. 1995 Oct 1;233(1):73-82
7588776
Biochim Biophys Acta. 1992 Jul 21;1117(1):25-32
1627588
Cell Metab. 2007 Feb;5(2):115-28
17276354